CRISPR/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells.
Cancer Res. 2018 Aug 15;78(16):4692-4703. doi: 10.1158/0008-5472.CAN-18-0030. Epub 2018 Jul 2.
Cancer Res. 2018.
PMID: 29967261